Ocular Therapeutix, Inc. Profile Avatar - Palmy Investing

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets R…

Biotechnology
US, Bedford [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of OCUL's Analysis
CIK: 1393434 CUSIP: 67576A100 ISIN: US67576A1007 LEI: - UEI: -
Secondary Listings
OCUL has no secondary listings inside our databases.